WIPI1 and major depressive disorder: Precise targeting is essential to avoid disrupting constitutive autophagy; future efforts should develop allosteric or partial modulators of WIPI1 activity while near‐term approaches may focus on biomarker‐guided stratification of MDD patients for indirect pathway modulation.